1. Home
  2. NCNA vs ATXG Comparison

NCNA vs ATXG Comparison

Compare NCNA & ATXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NCNA
  • ATXG
  • Stock Information
  • Founded
  • NCNA 1997
  • ATXG 2014
  • Country
  • NCNA United Kingdom
  • ATXG China
  • Employees
  • NCNA N/A
  • ATXG N/A
  • Industry
  • NCNA Biotechnology: Pharmaceutical Preparations
  • ATXG Professional Services
  • Sector
  • NCNA Health Care
  • ATXG Consumer Discretionary
  • Exchange
  • NCNA Nasdaq
  • ATXG Nasdaq
  • Market Cap
  • NCNA 4.4M
  • ATXG 3.9M
  • IPO Year
  • NCNA 2017
  • ATXG N/A
  • Fundamental
  • Price
  • NCNA $1.49
  • ATXG $0.62
  • Analyst Decision
  • NCNA Buy
  • ATXG
  • Analyst Count
  • NCNA 2
  • ATXG 0
  • Target Price
  • NCNA $25.00
  • ATXG N/A
  • AVG Volume (30 Days)
  • NCNA 138.4K
  • ATXG 14.8K
  • Earning Date
  • NCNA 11-26-2024
  • ATXG 11-14-2024
  • Dividend Yield
  • NCNA N/A
  • ATXG N/A
  • EPS Growth
  • NCNA N/A
  • ATXG N/A
  • EPS
  • NCNA N/A
  • ATXG N/A
  • Revenue
  • NCNA N/A
  • ATXG $4,958,444.00
  • Revenue This Year
  • NCNA N/A
  • ATXG N/A
  • Revenue Next Year
  • NCNA N/A
  • ATXG N/A
  • P/E Ratio
  • NCNA N/A
  • ATXG N/A
  • Revenue Growth
  • NCNA N/A
  • ATXG N/A
  • 52 Week Low
  • NCNA $1.49
  • ATXG $0.49
  • 52 Week High
  • NCNA $19.40
  • ATXG $1.77
  • Technical
  • Relative Strength Index (RSI)
  • NCNA 34.09
  • ATXG 47.08
  • Support Level
  • NCNA $1.53
  • ATXG $0.50
  • Resistance Level
  • NCNA $1.66
  • ATXG $0.67
  • Average True Range (ATR)
  • NCNA 0.09
  • ATXG 0.08
  • MACD
  • NCNA 0.05
  • ATXG 0.00
  • Stochastic Oscillator
  • NCNA -3.70
  • ATXG 58.24

About NCNA NuCana plc

NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.

About ATXG Addentax Group Corp.

Addentax Group Corp is an investment holding company. The company through its operating subsidiaries functions in the following segments; Garment manufacturing; Logistics services; Property management and subleasing. It generates maximum revenue from the Logistics services segment which provides logistics services including storage, transportation, warehousing, handling, packaging, and order processing. It also provides customs declaration and tax clearance services to its customers who export goods overseas. Geographically, the company derives all of its revenue from China.

Share on Social Networks: